The global market for bioreactors accessories is set to experience a positive growth trajectory in the coming years. According to a recent report by Transparency Market Research (TMR), the demand for innovative and flexible packaging is influencing the growth of this market. The report, titled, “Bioreactors Accessories Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025,” discusses the various factors that are accountable for the growth of the overall industry and upcoming market trends.
Get Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41135
Penile implants, also known as penile prostheses, inflatable penile prostheses, and internal penile prosthesis pumps are used in men experiencing erectile dysfunction (ED) or organic or treatment-resistant impotence that can be caused by physical conditions such as cardiovascular diseases, prostate cancer, diabetes, pelvic trauma, or Peyronie’s disease. Penile diseases could also be caused due to injuries to the spinal cord. ED may also occur due to a psychogenic component. Penile implants are embedded in the corpora cavernosa of the penis through a surgical procedure. Penile implants are considered to be the most effective treatment for ED. These implants are generally considered when less intrusive therapeutic medicines, like oral pharmaceuticals (such as Levitra, Viagra, and Cialis), penile infusions, or vacuum erection devices are unsuccessful, give an unsatisfactory result, or are contraindicated.
Based on the type of implant, the global market for penile implant can be been segmented into non-inflatable penile implants, two-piece inflatable penile implants, and three-piece (multi-component) inflatable penile implants. Based on end-user, the penile implants market has been classified into hospitals, clinics, and others.
The growing incidence of prostate cancer over the globe is one a primary factor driving the development of this market. The treatment for prostate cancer often requires the removal of the prostate gland which can result in impaired sexual function in at least half of the men who undergo this treatment. Although prostate cancer does not directly cause erectile dysfunction (ED), however, the treatment methods such as surgery with radical prostatectomy, hormone therapy, and radiation therapy can lead to ED. As penile implants help men with ED, the increase in the number of prostate cancer cases are expected to fuel the growth prospects of this market in the coming years.
The global penile implants market comprises of a small number of vendors that together hold a substantial market share. There are a few players in the regional or local markets that offer penile implants, for example, in India, Shah’s Penile Implant is a pivotal player offering a broad range of penile implant products across the country. The vendors in the market witness competition based on price of the product, variety, brands and availability.
Some of the prominent names operating in the global penile implants market are Promedon, Coloplast, Zephyr Surgical Implants and Boston Scientific Corporation